Back to search
Desmoplastic Small Round Cell Tumor
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Desmoplastic Small Round Cell Tumor trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Desmoplastic Small Round Cell Tumor trials you may qualify for3CAR is being done to investigate an immunotherapy for patients with solid tumors. It is a Phase I clinical trial evaluating the use of autologous T cells genet…
Patients participating in this study have DSRCT that has spread locally or to other parts of the body and can no longer be surgically removed without causing si…
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed s…
Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to…
This research is being done to test a new drug called PEEL-224 in combination with two commercially available drugs, Vincristine and Temozolomide, and to determ…
This trial is a translational, open-label, multi-sites, prospective and retrospective cohort study of 500 patients aimed at clinical and biological characteriza…
This is a phase I, open-label, non-randomized study that will enroll pediatric and young adult research participants with relapsed or refractory non-CNS solid t…
The study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and recurrent or refracto…